期刊文献+

耐多药结核患者外周血Th17细胞变化及其意义 被引量:2

Alteration and significance of Thl7 cells in peripheral blood of patients with multidrug-resistant tuberculosis
原文传递
导出
摘要 目的观察耐多药结核(MDR-TB)患者外周血辅助性T(Th)17细胞的水平,探讨人体抵抗MDR-TB的免疫学机制。方法选取MDR-TB患者25例(MDR-TB组),初治肺结核患者23例(TB组),健康正常人25例(HC组)。采用流式细胞分析法检测各组人群外周血Th17细胞占CD4+T细胞比例。应用流式微球分析法检测各组人群外周血Th17相关的白细胞介素(IL)17和IL-6的表达。结果 MDR-TB组和TB组患者外周血Th17/CD4+T细胞比例分别为(2.18±0.65)%和(1.32±0.34)%,明显高于HC组的(0.41±0.10)%(P<0.05);MDR-TB组的Th17细胞比例亦高于TB组(P<0.05)。MDR-TB组和TB组患者外周血IL-17水平分别为(6.45±1.88)pg/ml和(3.53±0.38)pg/ml,明显高于HC组的(2.39±0.46)pg/ml(P<0.05);MDR-TB和TB组间差异亦有统计学意义(P<0.05)。MDR-TB组患者外周血IL-6水平为(571.70±188.24)pg/ml,明显高于TB组的(18.50±5.87)pg/ml和HC组的(5.76±1.86)pg/ml(P<0.05)。三组外周血IL-17水平与IL-6水平呈正相关(r=0.824,P<0.01)。结论 MDR-TB患者外周血Th17细胞比例增加,IL-17I、L-6水平升高。Th17细胞可能参与MDR-TB的发病。 Objective:To study the alteration of T help 17(Th17) cells in peripheral blood of patients with multidrug-resistant tuberculosis(MDR-TB) and explore immunologic mechanism against MDR-TB in man.Methods:With flow cytometry and cytometric bead array(CBA),the ratio of Th17 in CD4+T cells,interleukin(IL)-17 and IL-6 were detected in 25 patients with multidrug-resistant tuberculosis(group MDR-TB),23 cases with pulmonary tuberculosis(group TB) and 25 healthy controls(group HC).Results:The ratio of Th17 in CD4+T cells was higher in groups of MDR-TB and TB than that in group HC [(2.18±0.65)% and(1.32±0.34)% vs.(0.41±0.10)%](P0.05),which was higher in group MDR-TB than that in group TB(P0.05).Plasma level of IL-17 was higher in groups of MDR-TB and TB than that in group HC[(6.45±1.88) pg/ml and(3.53±0.38) pg/ml vs.(2.39±0.46) pg/ml](P0.05),which was higher in group MDR-TB than that in group TB (P0.05).Plasma level of IL-17 was positively correlated to that of IL-6 in three groups(r=0.824,P0.01).Conclusion:The ratio of Th17 in CD4+T cells and plasma levels of IL-17 and IL-6 of peripheral blood are increased in patients with MDR-TB.Th17 cells may participate in the development of MDR-TB.
出处 《江苏医药》 CAS CSCD 北大核心 2010年第24期2873-2876,共4页 Jiangsu Medical Journal
基金 国家科技重大专项"十一五"计划(2008ZX10003-014)
关键词 耐多药结核 辅助性T细胞 Multidrug-resistance tuberculosis T help cells
  • 相关文献

参考文献10

  • 1Aziz MA, Wright A, Laszlo A, et al. Epidemiology of antitu- berculosis drug resistance (the Global Project on Anti-tuber- culosis Drug Resistance Surveillance): an updated analysis [J]. Lancet,2006,368(9553) :2142-2154.
  • 2肺结核诊断和治疗指南[J].中华结核和呼吸杂志,2001,24(2):70-74. 被引量:2872
  • 3Curtis MM, Way SS. Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens[J]. Immunolo- gy, 2009,126(2) : 177-185.
  • 4Zheng Y,Danilenko DM, Valdez P, et al. Interleukin-22, a T (H) 17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis[J]. Nature,2007,445(7128):648-651.
  • 5Aujla SJ, Dubin PJ, Kolls JK. Th17 cells and mucosal host defense[J]. Semin Immunol,2007,19(6) :377-382.
  • 6Shahemabadi AS, Hosseinl AZ, Shaghsernpour S, et al. Evalu- ation of T cell immune responses in multidrug-resistant tuber- culosis (MDR-TB) patients to Mycobacterium tuberculosis total lipid antigens[J]. Clin Exp Immunol, 2007,149 (2): 285- 294.
  • 7Geffner L, Yokobori N, Basile J, et al. Patients with multi- drug-resistant tuberculosis display impaired Th1 responses and enhanced regulatory T-cell levels in response to an out- break of multidrug-resistant mycobacterium tuberculosis M and Ra strains[J]. Infect Immun, 2009,77(11): 5025-5034.
  • 8Khader SA,Bell GK, Pearl JE, et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4^+ T cell responses after vaccination and during Mycobaeterium tuberculosis chal- lenge[J]. Nat Immunol,2007,8(4) :369-377.
  • 9Nurieva R, Yang XO, Martinez G, et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells [J]. Nature, 2007,448(7152) : 480-483.
  • 10Umemura M, Yahagi A, Harnada S, et al. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacteriurn boris Bacille Calmette-Guerin infection[J]. J Immunol,2007,178(6):3786-3796.

共引文献2871

同被引文献18

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部